新型冠状病毒肺炎

doi:10.3969/j.issn.1006-7795.2020.02.001

摘要/Abstract

摘要： 2019年新型冠状病毒肺炎肆虐全国，严重威胁我国人民生命健康。作为一种新发/突发传染病，其病原学、流行病学、发病机制、临床特点、治疗方案和预防策略均在探索和研究中，本文通过对最新的文献解读，帮助临床医师更好地了解这一新发/突发传染病。

关键词: 新型冠状病毒肺炎, 2019新型冠状病毒, 病原学, 发病机制

Abstract: 2019 novel coronavirus (2019-nCoV) infection represent a significant threat to Chinese public health. In order to help medical doctors to understand this emerging infectious disease well, the review paper presented recent achievements on etiology, epidemiology, pathogenesis, clinical characteristics, treatment plan and prevention strategy of 2019 nCoV infection.

Key words: COVID-19, 2019 novel coronavirus, etiology, pathogenesis

中图分类号:

R563.1

金荣华. 新型冠状病毒肺炎[J]. 首都医科大学学报, 2020, 41(2): 149-154.

Jin Ronghua. Coronavirus disease 2019[J]. Journal of Capital Medical University, 2020, 41(2): 149-154.

参考文献

[1] Gorbalenya A E, Baker S C, Baric R S, et al. Severe acute respiratory syndrome-related coronavirus:the species and its viruses-a statement of the Coronavirus Study Group. Preprint. bioRxiv. (2020-02-11)[2020-02-23]. https://doi.org/10.1101/2020.02.07.937862.
[2] Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses[J]. Trends Microbiol,2016,24:490-502.
[3] Chan J F, Lau S K, To K K, et al. Middle East respiratory syndrome coronavirus:another zoonotic beta coronavirus causing SARS-like disease[J]. Clin Microbiol Rev,2015,28:465.
[4] Zhong N S, Zheng B J, Li Y M, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003[J]. Lancet,2003,362:1353-1358.
[5] Ksiazek T G, Erdman D, Goldsmith C S, et al. A novel coronavirus associated with severe acute respiratory syndrome[J]. N Engl J Med,2003,348:1953-1966.
[6] Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med,2003,348:1967-1976.
[7] Zaki A M, van Boheemen S, Bestebroer T M, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med,2012,367:1814-1820.
[8] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med,2020,382:727-733.
[9] Gaunt E R, Hardie A, Claas E C, et al. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method[J]. J Clin Microbiol,2010,48:2940-2947.
[10] Duarte R, Furtado I, Sousa L,et al. The 2019 novel coronavirus (2019-nCoV):novel virus, old challenges. Acta Med Port,2020, 33:155-157. https://doi.org/10.20344/amp.13547.
[11] Zhou P, Yang X L, Wang X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020-02-03)[2020-02-23].https://doi.org/10.1038/s41586-020-2012-7.
[12] Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding. Lancet.(2020-01-30)[2020-02-23]. https://doi.org/10.1016/S0140-6736(20)30251-8.
[13] Xiao K, Zhai J, Feng Y, et al. Isolation and characterization of 2019-nCoV-like coronavirus from Malayan Pangolins. Preprint. bioRxiv. (2020-02-20)[2020-02-23]. https://doi.org/10.1101/2020.02.17.951335.
[14] 中华预防医学会新型冠状病毒肺炎防控专家组. 新型冠状病毒肺炎流行病学特征的最新认识[J].中华流行病学杂志,2020,41(2):139-144.
[15] WHO. Statement on the meeting of the International Health Regulations(2005) Emergency Committee regarding the outbreak of novel coronavirus 2019-nCoV).(2020-01-21)[2020-02-22].https://www.who.int/westernpacific/emergencies/covid-19.
[16] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志,2020,41(2):145-151.
[17] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. (2020-01-29)[2020-02-23].https://doi.org/10.1056/NEJMoa2001316.
[18] WHO. Novel coronavirus (2019-nCoV) technical guidance. N Engl J Med. (2020-01-29)[2020-02-23].https://doi.org/10.1056/NEJMoa2001316.
[19] Liu Y C, Liao C H, Chang C F, et al. A locally transmitted case of SARS-CoV-2 infection in Taiwan. N Engl J Med.(2020-02-12)[2020-02-23].https://doi.org/10.1056/NEJMc2001573.
[20] Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany. N Engl J Med.(2020-01-30)[2020-02-22].https://doi.org/10.1056/NEJMc2001468.
[21] Kupferschmidt K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed. Science. (2020-02-03)[2020-02-22].https://www.sciencemag.org/news/2020/02/paper-non-symptomatic-patient-transmitting-coronavirus-wrong.
[22] Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed 2019 novel coronavirus (2019-nCoV) infection. (2020-02-12)[2020-02-23]. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.
[23] Wan Y, Shang J, Graham R, et al. Receptor recognition by novel coronavirus from Wuhan:an analysis based on decade-long structural studies of SARS. J Virol. (2020-01-29)[2020-02-23].https://doi.org/10.1128/JVI.00127-20.
[24] Imai Y, Kuba K, Rao S, et al. Angiotensin converting enzyme 2 protects from severe acute lung failure[J]. Nature,2005,436:112-116.
[25] Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2(ACE2) in SARS coronavirus induced lung injury[J]. Nat Med,2005,11:875-879.
[26] Menachery V D, Eisfeld A J, Schafer A, et al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon stimulated gene responses[J]. Micro Bio,2014,5:e01174-14.
[27] Lau S K, Lau C C, Chan K H,et al.Delayed induction of proin flammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus:implications for pathogenesis and treatment[J]. J Gen Virol, 2013,94:2679-2690.
[28] Channappanavar R, Perlman S. Pathogenic human coronavirus infections:causes and consequences of cytokine storm and immunopathology[J]. Semin Immunopathol,2017,39:529.
[29] 沈华浩, 丁礼仁. 严重急性呼吸综合征发病机制研究现状[J]. 中华急诊医学杂志, 2003,12(8):568-569.
[30] Liu J, Zheng X, Tong Q, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. (2020-02-13)[2020-02-23]. https://doi.org/10.1002/jmv.25709.
[31] Guan W J, Ni Z Y, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China Preprint.bioRxiv. (2020-02-09)[2020-02-23].https://doi.org/10.1101/2020.02.06.20020974.
[32] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet,2020,395:497-506.
[33] 国家卫生健康委办公厅.新型冠状病毒感染的肺炎诊疗方案(试行第六版). (2020-02-21)[2020-02-22].http://www.nhe.gov.cn/yzygi/s7652m/202002/54elad5c2aac45c19eb541799b1637e9.shtml.